Terms: = Breast cancer AND AKT1, P31749, RAC-ALPHA, RAC, PRKBA, PKB-ALPHA, PKB, MGC99656, AKT, ENSG00000142208, 207 AND Treatment
3358 results:
1. Desmoglein 2 and desmocollin 2 depletions promote malignancy through distinct mechanisms in triple-negative and luminal breast cancer.
Han JY; Che N; Mo J; Zhang DF; Liang XH; Dong XY; Zhao XL; Sun BC
BMC Cancer; 2024 Apr; 24(1):532. PubMed ID: 38671389
[TBL] [Abstract] [Full Text] [Related]
2. Active substance and mechanisms of Actinidia chinensis Planch for the treatment of breast cancer was explored based on network pharmacology and in silico study.
Xu Y; Yang J; Han X; Gan C; Wei X
Medicine (Baltimore); 2024 Apr; 103(15):e37829. PubMed ID: 38608062
[TBL] [Abstract] [Full Text] [Related]
3. Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies.
Ali K; Nabeel M; Mohsin F; Iqtedar M; Islam M; Rasool MF; Hashmi FK; Hussain SA; Saeed H
Med Oncol; 2024 Apr; 41(5):112. PubMed ID: 38592510
[TBL] [Abstract] [Full Text] [Related]
4. Lapatinib antitumor effect is associated with PI3K and MAPK pathway: An analysis in human and canine prostate cancer cells.
Fonseca-Alves CE; Leis-Filho AF; Lacerda ZA; de Faria Lainetti P; Amorim RL; Rogatto SR
PLoS One; 2024; 19(4):e0297043. PubMed ID: 38564578
[TBL] [Abstract] [Full Text] [Related]
5. Decision regret of cancer patients after radiotherapy: results from a cross-sectional observational study at a large tertiary cancer center in Germany.
Rühle A; Wieland L; Hinz A; Mehnert-Theuerkauf A; Nicolay NH; Seidel C
J Cancer Res Clin Oncol; 2024 Mar; 150(3):167. PubMed ID: 38546873
[TBL] [Abstract] [Full Text] [Related]
6. Curcumin Inhibits the PPARδ-p-akt-GLUT1 Pathway and Ameliorates the Antiproliferative Effects of Doxorubicin in MDA-MB-231 Cells.
Thulasiraman P; Foret M; Pandit R; McAlister K
Asian Pac J Cancer Prev; 2024 Mar; 25(3):1035-1043. PubMed ID: 38546086
[TBL] [Abstract] [Full Text] [Related]
7. EB1089 Increases the Antiproliferative Response of Lapatinib in Combination with Antiestrogens in HER2-Positive breast cancer Cells.
Achounna AS; Ordaz-Rosado D; García-Quiroz J; Morales-Guadarrama G; Milo-Rocha E; Larrea F; Díaz L; García-Becerra R
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542136
[TBL] [Abstract] [Full Text] [Related]
8. Regulation of inflammatory response by LINC00346 via miR-25-3p-mediated modulation of the PTEN/PI3K/akt/NF-κB pathway.
Kim MJ; Lim SG; Cho DH; Lee JY; Suk K; Lee WH
Biochem Biophys Res Commun; 2024 May; 709():149828. PubMed ID: 38537596
[TBL] [Abstract] [Full Text] [Related]
9. Characterizing the Efficacy and Safety of Chemotherapy Plus Everolimus in HER2-Negative Metastatic breast cancer Harboring Altered PI3K/akt/mTOR.
Wang R; Zhu QY; Ye WW; Huang Y; Chen ZH; Zheng YB; Zou X; Wang J; Jiang DL; Wang XJ; Xu ZY; Cao WM
Discov Med; 2024 Mar; 36(182):527-537. PubMed ID: 38531793
[TBL] [Abstract] [Full Text] [Related]
10. Estrogen-receptor status determines differential regulation of α1- and α2-adrenoceptor-mediated cell survival, angiogenesis, and intracellular signaling responses in breast cancer cell lines.
Priyanka HP; Pratap UP; Nair RS; Vasantharekha R; ThyagaRajan S
Med Oncol; 2024 Mar; 41(5):92. PubMed ID: 38526769
[TBL] [Abstract] [Full Text] [Related]
11. Ropivacaine as a novel akt1 specific inhibitor regulates the stemness of breast cancer.
Ding L; Jiang H; Li Q; Li Q; Zhang TT; Shang L; Xie B; Zhu Y; Ding K; Shi X; Zhu T; Zhu Y
J Exp Clin Cancer Res; 2024 Mar; 43(1):90. PubMed ID: 38523299
[TBL] [Abstract] [Full Text] [Related]
12. Morusin inhibits breast cancer-induced osteolysis by decreasing phosphatidylinositol 3-kinase (PI3K)-mTOR signalling.
Zhang L; Li W; Chen X; Cao D; You S; Shi F; Luo Z; Li H; Zeng X; Song Y; Li N; Akimoto Y; Rui G; Chen Y; Wu Z; Xu R
Chem Biol Interact; 2024 May; 394():110968. PubMed ID: 38522564
[TBL] [Abstract] [Full Text] [Related]
13. Scutellarin, a flavonoid compound from Scutellaria barbata, suppresses growth of breast cancer stem cells in vitro and in tumor-bearing mice.
Ma H; Yue GG; Lee JK; Gao S; Yuen KK; Cheng W; Li X; Lau CB
Phytomedicine; 2024 Jun; 128():155418. PubMed ID: 38518647
[TBL] [Abstract] [Full Text] [Related]
14. Uncovering the effect and mechanism of Jiawei Xiaoyao Wan in treating breast cancer complicated with depression based on network pharmacology and experimental analysis.
Bai Y; Niu L; Song L; Dai G; Zhang W; He B; San W; Li S
Phytomedicine; 2024 Jun; 128():155427. PubMed ID: 38513380
[TBL] [Abstract] [Full Text] [Related]
15. Reduced chemokine C-C motif ligand 1 expression may negatively regulate colorectal cancer progression at liver metastatic sites.
Iwata M; Haraguchi R; Kitazawa R; Ito C; Ogawa K; Takada Y; Kitazawa S
J Cell Mol Med; 2024 Apr; 28(7):e18193. PubMed ID: 38506205
[TBL] [Abstract] [Full Text] [Related]
16. Synergy between PEDF and Doxorubicin in breast cancer Cells: Effects on Metastatic and Metabolic Pathways.
Abooshahab R; Al-Salami H; Dass CR
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38474001
[TBL] [Abstract] [Full Text] [Related]
17. Mammalian enabled protein enhances tamoxifen sensitivity of the hormone receptor-positive breast cancer patients by suppressing the akt signaling pathway.
He L; She C; Jiang S; Qi Z; Deng Z; Ji L; Cui Y; Wu J
Biol Direct; 2024 Mar; 19(1):21. PubMed ID: 38459605
[TBL] [Abstract] [Full Text] [Related]
18. EPAC inhibitor suppresses angiogenesis and tumor growth of triple-negative breast cancer.
Li Z; Liu Q; Cai Y; Ye N; He Z; Yao Y; Ding Y; Wang P; Qi C; Zheng L; Wang L; Zhou J; Zhang QQ
Biochim Biophys Acta Mol Basis Dis; 2024 Apr; 1870(4):167114. PubMed ID: 38447883
[TBL] [Abstract] [Full Text] [Related]
19. GSG2 promotes thyroid cancer via stabilizing AURKB and activating akt pathway.
Zhang F; Huang C
Aging (Albany NY); 2024 Mar; 16(6):5091-5107. PubMed ID: 38441546
[TBL] [Abstract] [Full Text] [Related]
20. Best of the year: Advanced breast cancer in 2023.
Schlam I; Chavez-MacGregor M
Breast; 2024 Apr; 74():103677. PubMed ID: 38401422
[TBL] [Abstract] [Full Text] [Related]
[Next]
